Strategic cooperation between ARTES & Sun Pharma

ARTES Biotechnology has entered into a strategic collaboration with a subsidiary of Sun Pharmaceutical Industries Ltd, an international specialty pharmaceutical company with a diversified product portfolio headquartered in Mumbai/India.

This step broadens ARTES’ international client base and demonstrates its ability to attract blue chip pharmaceutical companies. Under the collaboration agreement, ARTES will be responsible to deliver top-class cell lines and production processes for several pharmaceutical targets.

As part of the strategic collaboration, Sun Pharma’s subsidiary will also become a minority shareholder in ARTES.